AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

List of Acceliant eClinical Suite Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Cliantha Research Partners Life Sciences 1000 $400M United States Acceliant Acceliant eClinical Suite Clinical Trial Management 2013 n/a
In 2013, Cliantha Research Partners implemented Acceliant eClinical Suite as its Clinical Trial Management application to support clinical operations and biometrics. The deployment anchored Acceliant eClinical Suite across study setup and ongoing data management workflows, positioning the platform as the primary system for electronic data capture and patient reported outcomes within Cliantha's clinical teams. The implementation leveraged the suite's integrated EDC-ePRO components and built-in mobility to enable remote data capture and real time access to study data. Configuration work focused on study build, eCRF configuration, query management and role based access for data management and biometrics, reflecting capabilities typical of Clinical Trial Management platforms. Operationally the Acceliant eClinical Suite was rolled into Cliantha's clinical operations and biometrics groups, providing a unified interface for investigators, data managers and biometricians to manage study data. The deployment emphasized mobile enabled data entry and workflow automation to reduce manual handoffs and support distributed data management practices. Cliantha's Associate Director of Biometrics stated the solution was selected for its user friendly design and process oriented architecture that drives efficiency, lowers costs and accelerates clinical trial studies, and Acceliant's CTO described the platform as an integrated EDC-ePRO solution with mobility that allows data management from anywhere, anytime. Governance adjustments centered on standardizing data management workflows and aligning operational processes to the capabilities of the Acceliant eClinical Suite.
Lupin Limited Life Sciences 24006 $2.5B India Acceliant Acceliant eClinical Suite Clinical Trial Management 2017 n/a
In 2017, Lupin Limited implemented Acceliant eClinical Suite for BA/BE studies, selecting the platform to address a need for a robust, user friendly and cost effective clinical operations system. The engagement targeted Clinical Trial Management for bioavailability and bioequivalence trials and aimed to move control of clinical technology back in house because Lupin had been outsourcing their current technology and wanted an easy to use platform for the internal team. Implementation centered on study setup, configurable protocol workflows, and document management to remove the previous need to manage multiple discrete tools per trial. Acceliant eClinical Suite was configured to allow independent trial creation by clinical operations staff, to capture specific workflows such as blood sample collection time entry, and to centralize structured data collection and review processes consistent with Clinical Trial Management functionality. The deployment emphasized a feature rich configuration model that removed per trial constraints by providing unlimited pages, sites, and subjects and a licensing allowance of 100 trials per year, delivering a predictable and consolidated cost structure. Operational scope focused on Lupin's BA/BE study teams and internal clinical operations, with Acceliant eClinical Suite providing Clinical Trial Management capabilities across study design, participant tracking, and document control. Governance was adjusted toward decentralized provisioning and standardized workflows so study teams could provision trials and manage documents without individual trial pricing negotiations. Acceliant eClinical Suite now serves as Lupin Limited's centralized Clinical Trial Management platform for BA/BE studies, addressing prior tool fragmentation while enabling configurable data capture and review workflows.
PPD Professional Services 40000 $4.7B United States Acceliant Acceliant eClinical Suite Clinical Trial Management 2007 n/a
In 2007, PPD implemented Acceliant eClinical Suite for Clinical Trial Management. The Acceliant eClinical Suite was used alongside Excel and SAS output to perform data listing reviews and validation in accordance with Good Clinical Practices and PPD Global Standard Operating Procedures. Implementation focused on operationalizing clinical data review and validation workflows within the Clinical Trial Management environment, aligning the application with PPD data management and biostatistics groups to support listing generation, review reconciliation, and documented audit trails. Integrations were explicitly configured to consume SAS output and to export review artifacts into Excel for manual reconciliation, while standard Clinical Trial Management capabilities such as study and subject tracking, configurable review workflows, and controlled signoff were leveraged to enforce GCP and SOP controls. Governance centered on embedding SOP-aligned validation steps and formal review signoff into the Acceliant eClinical Suite workflow to ensure compliant data listing reviews and validation.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Acceliant eClinical Suite

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Acceliant eClinical Suite. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Acceliant eClinical Suite for Clinical Trial Management include:

  1. BPR Hub India, a India based Professional Services organization with 15 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Acceliant eClinical Suite Coverage

Acceliant eClinical Suite is a Clinical Trial Management solution from Acceliant.

Companies worldwide use Acceliant eClinical Suite, from small firms to large enterprises across 21+ industries.

Organizations such as PPD, Lupin Limited and Cliantha Research Partners are recorded users of Acceliant eClinical Suite for Clinical Trial Management.

Companies using Acceliant eClinical Suite are most concentrated in Professional Services and Life Sciences, with adoption spanning over 21 industries.

Companies using Acceliant eClinical Suite are most concentrated in United States and India, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Acceliant eClinical Suite across Americas, EMEA, and APAC.

Companies using Acceliant eClinical Suite range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 66.67%.

Customers of Acceliant eClinical Suite include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Acceliant eClinical Suite customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.